✦ LIBER ✦

Initial Combination Chemotherapy with Cisplatin, Methotrexate and Vinblastine in Locally Advanced Transitional Cell Carcinoma—Response Rate and Pitfalls

✍ Scribed by S. D. FOSSÅ; S. J. HARLAND; S. B. KAYE; D. RAGHAVAN; J. M. RUSSELL; M. K. B. PARMAR; BARBARA M. USCINSKA; R. WOOD

Book ID: 115196883
Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 604 KB
Volume: 70
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.1992.tb15696.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant methotrexate, vinblastine, d

Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder

✍ Ralph J. Miller Jr.; Robert R. Bahnson; Barbara Banner; Marc S. Ernstoff; Walter 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Methotrexate, vinblastine, doxorubicin a

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

✍ Han, K S; Joung, J Y; Kim, T S; Jeong, I G; Seo, H K; Chung, J; Lee, K H 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB

Methotrexate, vinblastine, epidoxorubici

Methotrexate, vinblastine, epidoxorubicin and cisplatin (M-VEC) in patients with locally advanced transitional bladder cancer

✍ A. Frassoldati; M. Federico; F. Barbieri; M. Brausi; C. Pollastri; G. Berri; G. 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 421 KB

Phase II trial of intermediate dose meth

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Howard Scher; Vaia Vlamis; Gera 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

## Background: This study was undertaken to determine whether the use of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin as first-line therapy increases the proportion of major responders and overall survival in patients with unresectable or metastatic tra

Accelerated methotrexate, vinblastine, d

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder

✍ Christopher Blick; Peter Hall; Thinn Pwint; Faisal Al-Terkait; Jeremy Crew; Thom 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

Combination chemotherapy with cisplatin,

Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck

✍ Marcel Rozencweig; Pierre Dodion; Uta Bruntsch; Walter Gallmeier; Michel Clavel; 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

A combination of cisplatin, methotrexate, bleomycin, and vincristine (CABO) was assessed in advanced epidermoid head and neck cancer. Among 72 patients with recurrent or metastatic disease and measurable lesions, there were 9 complete and 27 partial responses for an overall response rate of 50%. The